TrialDiabetes, obesity & metabolism2022

Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.

Matthew W Segar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.